Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-12-11

Clinical Trial Update: Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders) [NA]

View source ↗

Summary

Clinical trial comparing agonist versus classical hCG trigger in IVF across poor, normoresponders and high responders; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonadotropin-releasing hormone agonist trigger (Gonadotropin-releasing hormone agonist)
  • Human chorionic gonadotropin trigger (Human chorionic gonadotropin)

Snippet

Sponsor: Ginegorama S.L. | Conditions: Ovulation Induction, In Vitro Fertilization (IVF) | NA | Status: UNKNOWN